Stocks in play: MustGrow Biologics Corp
Provides an update of its organic mustard plant-derived crop protection technology pipeline. MustGrow has harnessed the mustard seed's natural defense mechanism for treatment of diseases, pests, and weeds. MustGrow Biologics Corp shares C.MGRO are trading down 0.02 cents at $3.80.
Read:
Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer
Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030
Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals
Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022
New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019